qualityassurance
★    

2026-01-16 13:52
(152 d 01:37 ago)

Posting: # 24547
Views: 850
 

 Repeat BE only for failed analyte [Study As­sess­ment]

Post reply
Hello Experts,

We have conducted BE of modified release fixed dose combination product. BE is successful for analyte-A while failing in AUCinf on a border line due to one outlier subject for analyte-B. Since our study is successful for analyte-A, is it possible that in new study (without change in formulation) we only analyse analyte-B and prove BE for analyte-b only. Will it be acceptable to regulatory authority such as EMA?

Any one has applied this approach in past and was it accepted by regulatory authorities?

Regards,
QA
 
UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
159 visitors (0 registered, 159 guests [including 18 identified bots]).
Forum time: 16:29 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5